This inventor holds 7 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Cephalon, Inc.. Active years: 1997-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Norristown, PA (US) (1997 - 2000)
- Ambler, PA (US) (2002)
- King of Prussia, PA (US) (2003)
Company Filing History:
7 out of 2,198 
1 out of 248 
Years Active: 1997-2003
Title: The Innovations of Israil Pendrak
Introduction
Israil Pendrak is a notable inventor based in Norristown, PA (US), recognized for his contributions to the field of biochemistry. With a total of 7 patents to his name, Pendrak has made significant strides in the development of fatty acid synthase inhibitors.
Latest Patents
Among his latest inventions, Pendrak has focused on compounds that serve as inhibitors of the fatty acid synthase FabH. This innovative approach has the potential to impact various therapeutic applications, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Pendrak has worked with prominent companies such as SmithKline Beecham Corporation and Cephalon, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.
Collaborations
Pendrak has collaborated with esteemed colleagues, including Robert A. Daines and William D. Kingsbury. These partnerships have fostered an environment of innovation and creativity, further enhancing his contributions to the field.
Conclusion
Israil Pendrak's work in developing fatty acid synthase inhibitors exemplifies his dedication to innovation in biochemistry. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile